✦ LIBER ✦

Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study

✍ Scribed by John Farley; Michael W. Sill; Michael Birrer; Joan Walker; Russell J. Schilder; J. Tate Thigpen; Robert L. Coleman; Brigitte E. Miller; Peter G. Rose; Heather A. Lankes

Book ID: 113963115
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 309 KB
Volume: 121
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.01.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin plus gemcitabine in previously

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group

✍ Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; D. Scott McMeekin; Shas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase II trial of cetuximab and carbopla

Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study

✍ Angeles Alvarez Secord; John A. Blessing; Deborah K. Armstrong; William H. Rodge 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Evaluation of Cisplatin and Cyclosporin

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

✍ Alberto Manetta; John A. Blessing; Jean A. Hurteau 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 29 KB

A phase II evaluation of cisplatin and 5

A phase II evaluation of cisplatin and 5-Fluorouracil in patients with advanced squamous cell carcinoma of the cervix: A gynecologic oncology group study

✍ Philip Bonomi; John Blessing; Harrison Ball; Parviz Hanjani; Philip J. DiSaia 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 340 KB

A phase II evaluation of tirapazamine pl

A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Allan Covens; John Blessing; David Bender; Robert Mannel; Mark Morgan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Phase II trial of the combination of bry

Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study

✍ Farr Nezhat; Scott Wadler; Franco Muggia; John Mandeli; Gary Goldberg; Jamal Rah 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB